News

TikTok Ban: Is The US Government Taking A Page From China's Censorship Book?
Are Dogecoin And Shiba Inu Due A Bounce? This Trader Sees 'Bull Flag' Forming For One Coin
Trump Vs. Biden: The President Plays The Marijuana Rescheduling Card, Voters Like The Thought Of It
Are Dogecoin And Shiba Inu Due A Bounce? This Trader Sees 'Bull Flag' Forming For One Coin
Trump Vs. Biden: The President Plays The Marijuana Rescheduling Card, Voters Like The Thought Of It
Aging Pet Population Is 'Solid Longer-Term Tailwind' For IDEXX Labs: Analyst
Eli Lilly 'On Its Way' To $1 Trillion Market Cap, Analysts Say: It's A 'Have' In A Sea Of 'Have Nots'

Recent News

Buy A House In Bay Area Or Use That Money Toward Early Retirement? As Reddit Goes Abuzz, 5 Things You Should Keep In Mind Before Taking A Decision
Investing in real estate in the Bay Area or pursuing FIRE can be overwhelming. Both have unique benefits and challenges.
Assassin's Creed Mirage Coming To iPhone 15 Pro, iPad In June
Assassin's Creed Mirage: optimized for iOS, iPadOS, and iPhone 15 Pro. Dive into Ubisoft's epic adventure on Apple devices.
Fastly Shares Drop After Q1 Results, Weak Revenue Guidance
Fastly reports quarterly sales of $133.52 million which beat the analyst consensus estimate of $133.1 million and represents a 13.57% increase over sales of $117.56 million from the same period last year.
Exxon Mobil Set To Close $60B Deal For Pioneer Natural Resources After Agreement With FTC
According to a report from the Wall Street Journal, the Federal Trade Commission will allege Sheffield has engaged in collusive activity which may have effected the price of oil.
Enovix Stock Soars On Blockbuster Q1 Sales
Enovix reports quarterly losses of 31 cents per share which missed the analyst consensus estimate of losses of 29 cents by 6.9%.
Zillow Shares Drop After Q1 Results: The Details
Zillow reports quarterly earnings of 36 cents per share which beat the analyst consensus estimate of 34 cents by 5.88%.
Are Hemp-THC Beverages Competing With Alcohol? Experts Discuss New Alternatives For Adult Beverages At Benzinga Cannabis Conference
Discover how THC beverages are reshaping social consumption and fueling growth in the Hospitality Sector.
Carvana Stock Jumps On Q1 Earnings: Revenue Beat, Vehicles Sold Up 16%, Strong Guidance And More
Carvana reports first-quarter revenue of $3.061 billion, which beat the consensus estimate of $2.673 billion, according to Benzinga Pro.
MGM Resorts Posts Better-Than-Expected Q1 Results
MGM Resorts reported quarterly earnings of 74 cents per share which beat the analyst consensus estimate of 56 cents by 32.14%.
DoorDash Reports Mixed Q1 Results: EPS Miss, Sales Beat
DoorDash reports quarterly losses of 6 cents per share which missed the analyst consensus estimate of losses of 4 cents by 50%.
Etsy Q1 Earnings: Revenue Miss, EPS Miss, 'Challenging Macroeconomic Environment'
Etsy reports first-quarter revenue of $645.954 million, which missed the consensus estimate of $646.33 million, according to Benzinga Pro. The company reported quarterly earnings of 48 cents per share, which missed estimates of 49 cents per share.
EXCLUSIVE: Health/Fitness-Focused Beachbody Partners With Telehealth Provider To Enable Pre-Tax Reimbursement For BODi Fitness Solutions
Beachbody & Dr. B partnership. Access $15 online consultations for common conditions, use pre-tax HSA/FSA funds. Say goodbye to onsite visits.
Federal Trade Commission Targets 'Junk Patent Listings' For Diabetes, Weight Loss, Asthma Drugs From Companies Like Novo Nordisk, AstraZeneca
The FTC intensifies efforts against pharmaceutical patent listings, disputing junk patents for diabetes, weight loss, asthma, and COPD medications. This initiative combats tactics hindering generic competition.
Qualcomm Q2 Earnings Highlights: Revenue Beat, EPS Beat, Record Automotive Results, On-Device AI Growth
Qualcomm reported second quarter financial results that topped expectations from analysts. A look at the highlights and guidance.
US Senate Grills UnitedHealth CEO Over Cyberattack Fallout, Ransom Payment
UnitedHealth Group's CEO addresses Senate concerns over cybersecurity risks, reassuring stability amid recent challenges. Learn more about the implications for healthcare and the economy.
Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
Cannara Biotech Inc. announced on Monday its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended Feb. 29, 2024. The company reported a 68% year-over-year increase in revenues for the first half of fiscal 2024, a metrics CFO Nicholas Sosiak called "a testament to our growing influence in the Quebec, Ontario, Alberta, and BC markets." "Our proactive steps towards streamlining assets align with our ambition to fortify our financial foundation as we relentlessly stay focused on gaining market share and becoming the leader in Canada, the second-largest cannabis market in the world," Sosiak said. "As for our long-term vision, we do see our future extend beyond our borders where Cannara is a globally recognized brand synonymous with excellence and value in cannabis."
Super Micro Updates Fiscal Guidance As Nvidia Shifts, 4 Analysts Provide Perspectives
Wedbush analyst maintains Super Micro Computer Inc with Neutral rating and raises price target from $530 to $800, citing sales momentum and concerns about margins and competition in AI server market.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Stock Brokers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers